JARID2 and the PRC2 complex regulate skeletal muscle differentiation through regulation of canonical Wnt signaling
Open Access
- 17 August 2018
- journal article
- research article
- Published by Springer Nature in Epigenetics & Chromatin
- Vol. 11 (1) , 1-20
Abstract
JARID2 is a non-catalytic member of the polycomb repressive complex 2 (PRC2), which is known to regulate developmental target genes in embryonic stem cells. Here, we provide mechanistic insight into the modulation of Wnt signaling by JARID2 during murine skeletal muscle differentiation. We show that JARID2 is expressed in proliferating myoblasts, but downregulated upon muscle differentiation. Unexpectedly, depletion of JARID2 or the catalytic subunit of the PRC2 complex, EZH2, inhibited differentiation, suggesting that JARID2 and the PRC2 complex are required to initiate this process. Expression of the myogenic regulatory factors required to promote differentiation, MYOD and MYOG, was downregulated in the absence of JARID2, even though decreases in the methylation of histone H3 lysine 27 (H3K27me3) were observed on both promoters. We found that activation of the Wnt signaling pathway upregulated MYOD and restored differentiation. Activation of the Wnt pathway in JARID2 depleted cells caused β-catenin to translocate to the nucleus, where it bound to and activated the Myod1 promoter. We show that the Wnt antagonist SFRP1 is highly upregulated in the absence of JARID2 and is a direct target of JARID2 and the PRC2 complex. Ectopic expression of SFRP1 blocked MYOD and late muscle gene expression and inhibited the translocation of β-catenin to the nucleus. Finally, we show that JARID2 and SFRP1 are inversely correlated in melanoma, confirming that the JARID2-mediated repression of SFRP1 extends beyond skeletal muscle and has important implications in many cellular systems, including cancer. We show that JARID2 and the PRC2 complex regulate muscle differentiation by modulating Wnt signaling through the direct repression of Wnt antagonists.Keywords
Funding Information
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (RAR068622)
This publication has 55 references indexed in Scilit:
- Jarid2 (Jumonji, AT Rich Interactive Domain 2) Regulates NOTCH1 Expression via Histone Modification in the Developing HeartJournal of Biological Chemistry, 2012
- Polycomb-mediated repression during terminal differentiation: what don't you want to be when you grow up?: Figure 1.Genes & Development, 2011
- Genome-wide remodeling of the epigenetic landscape during myogenic differentiationProceedings of the National Academy of Sciences, 2011
- Endothelial Jarid2/Jumonji Is Required for Normal Cardiac Development and Proper Notch1 ExpressionJournal of Biological Chemistry, 2011
- Polycomb EZH2 controls self-renewal and safeguards the transcriptional identity of skeletal muscle stem cellsGenes & Development, 2011
- TNF/p38α/Polycomb Signaling to Pax7 Locus in Satellite Cells Links Inflammation to the Epigenetic Control of Muscle RegenerationCell Stem Cell, 2010
- Jumonji Modulates Polycomb Activity and Self-Renewal versus Differentiation of Stem CellsCell, 2009
- Jarid2/Jumonji Coordinates Control of PRC2 Enzymatic Activity and Target Gene Occupancy in Pluripotent CellsCell, 2009
- A Temporal Switch from Notch to Wnt Signaling in Muscle Stem Cells Is Necessary for Normal Adult MyogenesisCell Stem Cell, 2008
- Histone Methyltransferase Activity of a Drosophila Polycomb Group Repressor ComplexCell, 2002